Immunic Inc IMUX Q1 2026 Earnings EPS Misses Estimates on RD Investment Stock Rises 79 on Pipeline Optimism Ziff Davis Inc Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist MARPS Q4 2025 Earnings Royalty Income Holds Steady Amid No Revenue Expectation LIXT Q4 2024 Earnings ClinicalStage Biotech Reports perShare Loss as Development Continues AMN Healthcare Q1 2026 Earnings Strong EPS Beat Drives Stock Rally